Stock Screener
Stock Research
Market Indexes
Precious Metals
Energy
Commodities
Exchange Rates
Interest Rates
Futures
Economy
Global Metrics

Genmab Current Ratio 2019-2019 | GMAB

Genmab current ratio from 2019 to 2019. Current ratio can be defined as a liquidity ratio that measures a company's ability to pay short-term obligations.
  
Genmab Current Ratio Historical Data
Date Current Assets Current Liabilities Current Ratio
2019-09-30 $1.83B $0.10B 18.72
2019-06-30 $1.18B $0.08B 14.89
2019-03-31 $0.00B 0.00
2018-12-31 $1.18B $0.07B 16.77
Sector Industry Market Cap Revenue
Medical Medical - Biomedical and Genetics $2.859B $0.479B
Genmab A/S is a biotechnology company. It specializes in development of antibody therapeutics for the treatment of cancer. The company's product pipeline includes DARZALEX(R), Arzerra(R), tisotumab vedotin, enapotamab vedotin, HexaBody-DR5/DR5(R) and DuoBody-CD3xCD20 (R),which are in clinical stage. Genmab A/S is based in Copenhagen V, Denmark.
Stock Name Country Market Cap PE Ratio
Amgen (AMGN) United States $140.221B 16.15
CSL (CSLLY) Australia $87.693B 0.00
Gilead Sciences (GILD) United States $85.562B 10.60
Vertex Pharmaceuticals (VRTX) United States $56.714B 57.89
Biogen (BIIB) United States $53.023B 9.10
Illumina (ILMN) United States $47.333B 51.93
Regeneron Pharmaceuticals (REGN) United States $40.861B 17.89
Actelion (ALIOF) Switzerland $29.891B 0.00
Alexion Pharmaceuticals (ALXN) United States $24.889B 12.29
Incyte (INCY) United States $20.000B 46.42
Seattle Genetics (SGEN) United States $19.240B 0.00
SINO PHARMACEUT (SBMFF) Hong Kong, SAR China $16.114B 0.00
BioMarin Pharmaceutical (BMRN) United States $14.532B 0.00
Genmab (GNMSF) Denmark $13.473B 59.51
Alnylam Pharmaceuticals (ALNY) United States $13.447B 0.00
Galapagos (GLPG) Belgium $11.816B 30.44
Exact Sciences (EXAS) United States $11.090B 0.00
Bio-Rad Laboratories (BIO.B) United States $10.822B 51.94
QIAGEN (QGEN) Netherlands $9.359B 30.51
BeiGene (BGNE) Cayman Islands $8.604B 0.00
Bio-Techne Corp (TECH) United States $8.320B 55.69
Amarin (AMRN) Ireland $8.212B 0.00
Sarepta Therapeutics (SRPT) United States $7.489B 0.00
ACADIA Pharmaceuticals (ACAD) United States $6.857B 0.00
Guardant Health (GH) United States $6.811B 0.00
BioNTech SE (BNTX) Germany $6.752B 0.00
Medicines (MDCO) United States $6.699B 0.00
Horizon Therapeutics Public (HZNP) Ireland $6.151B 15.64
Moderna (MRNA) United States $6.148B 0.00
Reata Pharmaceuticals (RETA) United States $6.086B 0.00
ARGENX SE-ADR (ARGX) Netherlands $5.943B 0.00
Exelixis (EXEL) United States $5.363B 15.09
Ascendis Pharma (ASND) Denmark $4.958B 0.00
Bluebird Bio (BLUE) United States $4.651B 0.00
Repligen (RGEN) United States $4.640B 84.08
China Biologic Products (CBPO) China $4.594B 25.88
MorphoSys AG (MOR) Germany $4.535B 0.00
Spark Therapeutics (ONCE) United States $4.259B 0.00
Mirati Therapeutics (MRTX) United States $4.185B 0.00
Immunomedics (IMMU) United States $4.008B 0.00
Adaptive Biotechnologies (ADPT) United States $3.938B 0.00
Intercept Pharmaceuticals (ICPT) United States $3.795B 0.00
CRISPR Therapeutics AG (CRSP) Switzerland $3.645B 0.00
Blueprint Medicines (BPMC) United States $3.629B 0.00
Alkermes (ALKS) Ireland $3.347B 0.00
MyoKardia (MYOK) United States $3.017B 0.00
UniQure (QURE) Netherlands $3.005B 0.00
Emergent Biosolutions (EBS) United States $2.789B 27.71
NeoGenomics (NEO) United States $2.779B 147.89
Halozyme Therapeutics (HALO) United States $2.743B 0.00
Acceleron Pharma (XLRN) United States $2.650B 0.00
Zai Lab (ZLAB) China $2.500B 0.00
Ultragenyx Pharmaceutical (RARE) United States $2.468B 0.00
Amicus Therapeutics (FOLD) United States $2.423B 0.00
Arena Pharmaceuticals (ARNA) United States $2.371B 5.52
RA PHARMCTL INC (RARX) United States $2.232B 0.00
Insmed (INSM) United States $2.067B 0.00
Ligand Pharmaceuticals (LGND) United States $1.876B 36.10
Myriad Genetics (MYGN) United States $1.860B 27.47
Akcea Therapeutics (AKCA) United States $1.830B 0.00
Dicerna Pharmaceuticals (DRNA) United States $1.829B 0.00
Denali Therapeutics (DNLI) United States $1.799B 0.00
Zymeworks (ZYME) Canada $1.688B 0.00
Momenta Pharmaceuticals (MNTA) United States $1.667B 0.00
Principia Biopharma (PRNB) United States $1.625B 0.00
Epizyme (EPZM) United States $1.622B 0.00
REGENXBIO (RGNX) United States $1.546B 0.00
Editas Medicine (EDIT) United States $1.546B 0.00
Arvinas (ARVN) United States $1.456B 0.00
Fate Therapeutics (FATE) United States $1.430B 0.00
Nabriva Therapeutics AG (NBRV) Ireland $1.395B 0.00
Innoviva (INVA) United States $1.386B 4.08
Alector (ALEC) United States $1.374B 0.00
Athenex (ATNX) United States $1.315B 0.00
Coherus BioSciences (CHRS) United States $1.280B 0.00
WAVE Life Sciences (WVE) Singapore $1.247B 0.00
Zealand Pharma (ZLDPF) Denmark $1.129B 0.00
Orchard Therapeutics (ORTX) United Kingdom $1.088B 0.00
Pharming Group (PHGUF) Netherlands $1.025B 0.00
Sangamo Therapeutics (SGMO) United States $1.006B 0.00
Zealand Pharma (ZEAL) Denmark $0.992B 0.00
Codexis (CDXS) United States $0.926B 0.00
ZIOPHARM Oncology Inc (ZIOP) United States $0.918B 0.00
Vanda Pharmaceuticals (VNDA) United States $0.906B 7.61
Achillion Pharmaceuticals (ACHN) United States $0.870B 0.00
Twist Bioscience (TWST) United States $0.861B 0.00
BAVARIAN NORDIC (BVNRY) Denmark $0.838B 0.00
Intellia Therapeutics (NTLA) United States $0.822B 0.00
Vericel (VCEL) United States $0.794B 296.17
MiMedx (MDXG) United States $0.791B 0.00
DBV Technologies S.A (DBVT) France $0.780B 0.00
Anika Therapeutics (ANIK) United States $0.763B 24.77
ANI Pharmaceuticals (ANIP) United States $0.749B 12.77
Revance Therapeutics (RVNC) United States $0.742B 0.00
Clovis Oncology (CLVS) United States $0.736B 0.00
Heska (HSKA) United States $0.733B 187.20
UROGEN PHARMA (URGN) United States $0.698B 0.00
Intra-Cellular Therapies (ITCI) United States $0.691B 0.00
Sorrento Therapeutics (SRNE) United States $0.686B 0.00
Cellectis S.A (CLLS) France $0.678B 0.00
Adverum Biotechnologies (ADVM) United States $0.678B 0.00
Mesoblast (MESO) Australia $0.664B 0.00
Cara Therapeutics (CARA) United States $0.656B 0.00
GENFIT S.A (GNFT) France $0.624B 0.00
Kadmon Holdings (KDMN) United States $0.615B 0.00
Retrophin (RTRX) United States $0.594B 0.00
Basilea Pharmaceutica AG (BPMUF) Switzerland $0.590B 0.00
AC Immune SA (ACIU) Switzerland $0.590B 13.64
PHARMA MAR SA (PHMMF) Spain $0.584B 0.00
BioDelivery Sciences (BDSI) United States $0.578B 0.00
Cytokineticsorporated (CYTK) United States $0.572B 0.00
Dynavax Technologies (DVAX) United States $0.548B 0.00
Lexicon Pharmaceuticals (LXRX) United States $0.539B 3.73
Agenus (AGEN) United States $0.526B 0.00
Autolus Therapeutics (AUTL) United Kingdom $0.522B 0.00
Prothena (PRTA) Ireland $0.517B 0.00
OXFORD BIOMEDCL (OXBDF) United Kingdom $0.514B 0.00
Stemline Therapeutics (STML) United States $0.511B 0.00
Precision BioSciences (DTIL) United States $0.496B 0.00
Sinovac Biotech (SVA) China $0.460B 0.00
AnaptysBio (ANAB) United States $0.439B 0.00
Avid Bioservices (CDMO) United States $0.413B 0.00
Arcus Biosciences (RCUS) United States $0.410B 0.00
Merus (MRUS) Netherlands $0.402B 0.00
PDL BioPharma (PDLI) United States $0.392B 9.80
Bellus Health (BLU) Canada $0.389B 0.00
OSMOTICA PHARM (OSMT) United States $0.384B 0.00
AMAG Pharmaceuticals (AMAG) United States $0.384B 0.00
Gritstone Oncology (GRTS) United States $0.368B 0.00
Puma Biotechnology (PBYI) United States $0.362B 0.00
Xenon Pharmaceuticals (XENE) Canada $0.362B 0.00
Pfenex (PFNX) United States $0.353B 0.00
Starpharma Holdings (SPHRY) Australia $0.331B 0.00
CytomX Therapeutics (CTMX) United States $0.323B 0.00
Cellular Biomedicine (CBMG) United States $0.322B 0.00
Kindred Biosciences (KIN) United States $0.322B 0.00
Aquinox Pharmaceuticals (NLTX) United States $0.319B 0.00
Scholar Rock Holding (SRRK) United States $0.311B 0.00
Seres Therapeutics (MCRB) United States $0.305B 0.00
Geron (GERN) United States $0.300B 0.00
Kamada (KMDA) Israel $0.297B 8.67
MannKind (MNKD) United States $0.289B 0.00
Compugen (CGEN) Israel $0.287B 0.00
Cue Biopharma (CUE) United States $0.285B 0.00
Exicure (XCUR) United States $0.277B 0.00
Inovio Pharmaceuticals (INO) United States $0.271B 0.00
Cel-Sci (CVM) United States $0.267B 0.00
Albireo Pharma (ALBO) United States $0.266B 0.00
IVERIC Bio (ISEE) United States $0.264B 0.00
Sutro Biopharma (STRO) United States $0.259B 0.00
Senesco Technologies (ELOX) United States $0.253B 0.00
ADMA Biologics Inc (ADMA) United States $0.246B 0.00
Syndax Pharmaceuticals (SNDX) United States $0.240B 0.00
ChromaDex (CDXC) United States $0.235B 0.00
Theratechnologies (THTX) Canada $0.232B 0.00
Aeglea BioTherapeutics (AGLE) United States $0.231B 0.00
Biofrontera AG (BFRA) Germany $0.221B 0.00
NantKwest (NK) United States $0.216B 0.00
Proteostasis Therapeutics (PTI) United States $0.210B 0.00
Spero Therapeutics (SPRO) United States $0.209B 0.00
Abeona Therapeutics (ABEO) United States $0.204B 0.00
POXEL SA FRANCE (PXXLF) France $0.203B 0.00
XOMA (XOMA) United States $0.202B 0.00
Athersys (ATHX) United States $0.202B 0.00
Protagonist Therapeutics (PTGX) United States $0.199B 0.00
Syros Pharmaceuticals (SYRS) United States $0.196B 0.00
Cerecor (CERC) United States $0.194B 0.00
Pieris Pharmaceuticals (PIRS) United States $0.190B 0.00
Affimed (AFMD) Germany $0.190B 0.00
ARAVIVE, INC (ARAV) United States $0.190B 0.00
Palatin Technologies (PTN) United States $0.186B 5.06
Mersana Therapeutics (MRSN) United States $0.183B 0.00
VBI Vaccines (VBIV) United States $0.176B 0.00
Five Prime Therapeutics (FPRX) United States $0.170B 0.00
CorMedix Inc (CRMD) United States $0.165B 0.00
EYEPOINT PHARMACEUTICALS, INC (EYPT) United States $0.163B 0.00
Alcobra (ARCT) United States $0.162B 0.00
Dyadic (DYAI) United States $0.162B 0.00
Nymox Pharmaceutical (NYMX) Canada $0.158B 0.00
Windtree Therapeutics (WINT) United States $0.144B 0.00
Aptinyx (APTX) United States $0.142B 0.00
Bicycle Therapeutics (BCYC) United Kingdom $0.139B 0.00
Fortress Biotech (FBIO) United States $0.138B 0.00
Arsanis (XFOR) United States $0.136B 0.00
Arbutus Biopharma (ABUS) Canada $0.136B 0.00
Northwest Biotherapeutics (NWBO) United States $0.135B 0.00
Newron Pharmaceuticals SpA (NWPHF) Italy $0.134B 0.00
Prometic Life Sciences (LMNL) Canada $0.132B 0.00
Adaptimmune Therapeutics (ADAP) United Kingdom $0.130B 0.00
TELA Bio (TELA) United States $0.128B 0.00
Nicox SA (NICXF) France $0.125B 0.00
Enzo Biochem (ENZ) United States $0.122B 0.00
SESEN BIO, INC (SESN) United States $0.114B 0.00
AVEO Pharmaceuticals (AVEO) United States $0.113B 0.00
PHASEBIO PHARMA (PHAS) United States $0.111B 0.00
Celyad SA (CYAD) Belgium $0.107B 0.00
Menlo Therapeutics (MNLO) United States $0.106B 0.00
Novavax (NVAX) United States $0.106B 0.00
Paratek Pharmaceuticals (PRTK) United States $0.103B 0.00
BioTime (LCTX) United States $0.103B 5.28
Verastem (VSTM) United States $0.101B 0.00
Strongbridge Biopharma (SBBP) United States $0.099B 2.65
Aduro Biotech (ADRO) United States $0.095B 0.00
Acorda Therapeutics (ACOR) United States $0.088B 0.00
Antibe Therapeutics (ATBPF) Canada $0.088B 0.00
Synlogic (SYBX) United States $0.087B 0.00
Adocia (ADOCY) France $0.086B 0.00
OvaScience (MLND) United States $0.084B 0.00
Emmaus Life Sciences (EMMA) United States $0.082B 0.00
VTv Therapeutics (VTVT) United States $0.082B 0.00
Vaccinex (VCNX) United States $0.078B 0.00
ANIXA BIOSCIENCES INC (ANIX) United States $0.078B 0.00
Selecta Biosciences (SELB) United States $0.077B 0.00
Liquidia Technologies (LQDA) United States $0.071B 0.00
Clearside Biomedical (CLSD) United States $0.071B 0.00
Trevena (TRVN) United States $0.071B 0.00
ASLAN Pharmaceuticals (ASLN) Singapore $0.068B 0.00
Organovo Holdings (ONVO) United States $0.066B 0.00
Catabasis Pharmaceuticals (CATB) United States $0.066B 0.00
Prima BioMed (IMMP) Australia $0.066B 0.00
Spring Bank Pharmaceuticals (SBPH) United States $0.065B 0.00
Merrimack Pharmaceuticals (MACK) United States $0.060B 0.00
NewLink Genetics (NLNK) United States $0.060B 0.00
Catalyst Biosciences (CBIO) United States $0.060B 0.00
Pluristem Therapeutics (PSTI) Israel $0.055B 0.00
Curis (CRIS) United States $0.051B 0.00
Applied Genetic Technologies (AGTC) United States $0.049B 0.00
Checkpoint Therapeutics (CKPT) United States $0.049B 0.00
Idera Pharmaceuticals (IDRA) United States $0.047B 0.00
Orgenesis (ORGS) United States $0.045B 2.92
AquaBounty Technologies (AQB) United States $0.044B 0.00
Alimera Sciences (ALIM) United States $0.042B 0.00
Vascular Biogenics (VBLT) Israel $0.042B 0.00
AmpliPhi Biosciences (ARMP) United States $0.041B 0.00
Aridis Pharmaceuticals (ARDS) United States $0.041B 0.00
Protalix BioTherapeutics (PLX) Israel $0.041B 0.00
DiaMedica Therapeutics (DMAC) United States $0.040B 0.00
Evogene (EVGN) Israel $0.039B 0.00
AIT Therapeutics (XAIR) United States $0.039B 0.00
Celsion (CLSN) United States $0.036B 0.00
Celldex Therapeutics (CLDX) United States $0.035B 0.00
Sunesis Pharmaceuticals (SNSS) United States $0.034B 0.00
Stellar Biotechnologies (EDSA) Canada $0.034B 0.00
Oncobiologics (OTLK) United States $0.032B 0.00
Apricus Biosciences (SEEL) United States $0.031B 0.00
VIVUS (VVUS) United States $0.029B 0.00
Fibrocell Science Inc (FCSC) United States $0.029B 16.67
BioCardia (BCDA) United States $0.028B 0.00
Aptevo Therapeutics (APVO) United States $0.028B 0.00
Novogen (KZIA) Australia $0.028B 0.00
INNOVATE BIOPHARMACEUTICALS, INC (INNT) United States $0.028B 0.00
Bionano Genomics (BNGO) United States $0.027B 0.00
Caladrius Biosciences (CLBS) United States $0.026B 0.00
Soligenix (SNGX) United States $0.026B 0.00
VistaGen Therapeutics (VTGN) United States $0.025B 0.00
Aerpio Pharmaceuticals (ARPO) United States $0.023B 0.00
PLANET GREEN HOLDINGS CORP (PLAG) China $0.023B 0.00
Entera Bio (ENTX) Israel $0.021B 0.00
Signal Genetics (MGEN) United States $0.020B 0.00
CollPlant Holdings (CLGN) Israel $0.020B 0.00
Unum Therapeutics (UMRX) United States $0.017B 0.00
Pulmatrix (PULM) United States $0.017B 0.00
Aytu Bioscience (AYTU) United States $0.017B 0.00
AEterna Zentaris (AEZS) United States $0.016B 0.00
IMMURON (IMRN) Australia $0.014B 0.00
MYOS RENS Technology (MYOS) United States $0.013B 0.00
TOCAGEN INC (TOCA) United States $0.013B 0.00
Prana Biotechnology (ATHE) Australia $0.012B 0.00
Advaxis (ADXS) United States $0.011B 0.00
Cyclacel Pharmaceuticals (CYCC) United States $0.011B 0.00
TrovaGene (TROV) United States $0.010B 0.00
Titan Pharmaceuticals (TTNP) United States $0.010B 0.00
Genetic Technologies (GENE) Australia $0.010B 0.00
Cesca Therapeutics (THMO) United States $0.008B 0.00
Cleveland BioLabs (CBLI) United States $0.008B 0.00
TRACON Pharmaceuticals (TCON) United States $0.008B 0.00
IBio (IBIO) United States $0.008B 0.00
Benitec Biopharma (BNTC) Australia $0.007B 0.00
BioPharmX (BPMX) United States $0.005B 0.00
Neuralstem (SNCA) United States $0.003B 0.00